March 17, 2023
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
March 3, 2023
Albert Baldwin, PhD, is the 2022 recipient of the Hyman L. Battle Distinguished Cancer Research Award. The award recognizes exceptional cancer research at UNC-Chapel Hill.
January 25, 2023
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
September 26, 2022
The NCI awarded $9.3 million in support of two five-year research projects from researchers in the UNC Lineberger Pancreatic Cancer Center of Excellence in partnership with other institutions.
July 22, 2022
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
February 24, 2022
Greg Wang, PhD, and colleagues have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development.
January 31, 2022
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
January 26, 2022
In a laboratory study, UNC Lineberger researchers report a novel combination of two drugs delivered in a nanoparticle formulation may suggest an approach for a less toxic treatment for medulloblastoma, the most common pediatric brain cancer.
January 18, 2022
Pengda Liu, PhD, was awarded the grant to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma, a bone cancer that occurs mainly in children.
November 11, 2020
Greg Wang, PhD, and colleagues have identified an evolutionarily conserved pathway responsible for “closing down” gene activity in the mammalian cell.
